Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Glaukos Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Celldex Therapeutics Inc. June 25, 202699.4%
-
Glaukos Corporation May 28, 202678.5%
-
Celldex Therapeutics Inc. June 5, 202599.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Seaport Therapeutics Inc. | Open-market purchase | +5,000 | $19.87 | $99,325 |
| May 28, 2026 | Glaukos Corporation | Grant or award | +1,878 | — | — |
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +13,406 | — | — |
| Jan 2, 2026 | Glaukos Corporation | Grant or award | +623 | — | — |
| May 29, 2025 | Glaukos Corporation | Grant or award | +2,108 | — | — |
| Jan 2, 2025 | Glaukos Corporation | Grant or award | +461 | — | — |
| May 30, 2024 | Glaukos Corporation | Grant or award | +1,716 | — | — |
| Jan 2, 2024 | Glaukos Corporation | Grant or award | +895 | — | — |
| Jun 1, 2023 | Glaukos Corporation | Grant or award | +3,230 | — | — |
| Jan 3, 2023 | Glaukos Corporation | Grant or award | +1,572 | — | — |
Questions about Denice Torres
What boards is Denice Torres on?
Denice Torres sits on the boards of Celldex Therapeutics Inc., Glaukos Corporation and Seaport Therapeutics Inc.
How long has Denice Torres served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.